And IMU has been developing its pipeline of discoveries for 13 years with a market cap of around $417m. Has done a truck load of investor presentations, conferences, road shows, peer reviews yet no BIG Pharma has come to the table to date. IMU could be a multi bagger, however, that could be years away.
SNT is a flyweight contesting in a heavy weight division with a MC of $34m with bugger all revenue and importantly net or profit margin of minus 1,069% up nearly 50% on the last quarter (March 2024) with net income minus $4.3m, up about 13% (last quarter).
As an SNT investor I hope it is successful however, the only way forward without losing its IP is consider merging with another ASX pharma company IMO.
And IMU has been developing its pipeline of discoveries for 13...
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $43.87M | |||
| Open | High | Low | Value | Volume |
| 3.5¢ | 3.5¢ | 3.4¢ | $14.00K | 402.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 440288 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 374403 | 3 |
View Market Depth
| Last trade - 15.50pm 30/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |